In summary our study investigated clinical, OCT and serum biomarkers (sNfL, GFAP and GDF15) differences in a population of chronic primary mitochondrial optic neuropathies: LHON and ADOA. This evidence concerns the gene GFAP and autosomal dominant optic atrophy.